Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Leap Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Deciphera Pharmaceuticals, LLC
pharmaand GmbH
GOG Foundation